Psoriatic Arthritis

In a large randomized trial, researchers investigated the efficacy of a human IgG1κ monoclonal antibody at improving symptoms and slowing disease progression among patients with psoriatic arthritis.

In a large randomized trial, researchers investigated the efficacy of a human IgG1κ monoclonal antibody at improving symptoms and slowing disease progression among patients with psoriatic arthritis.

Expansion of therapeutic possibilities for psoriatic arthritis have highlighted the need to identify residual disease and opportunities to adjust treatment.

In a recent study, researchers examined the potential of sonographic enthesitis as a marker of joint damage in patients with PsA.

In a recent study, researchers examined the potential of sonographic enthesitis as a marker of joint damage in patients with PsA.

A recent study examined the prevalence of and risk factors associated with enthesitis in patients with psoriatic arthritis.

The FDA approved ustekinumab-auub as an interchangeable biosimilar with ustekinumab for multiple inflammatory diseases.

Prediagnosis symptoms revealed in new study suggest patients with psoriatic arthritis may be diagnosed earlier.

Researchers found that the depressive symptoms often found among patients with psoriatic arthritis may be due to serum interleukin rather than disability alone.